SAVIMS

SAVIMS logo white
Menu

Vaccine safety & adverse events

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

German Doctors and Lawyers Raise Concerns Over Covid Injections

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Wilson, R. (2021, August 31). German doctors and lawyers assess blood smears from people who have had Covid injections: “For me this is euthanasia. For me this is mass murder, a crime on a grand scale.” Expose News. https://expose-news.com/2021/08/31/german-doctors-and-lawyers-assess-blood-smears-from-people-who-have-had-covid-injections-for-me-this-is-euthanasia-for-me-this-is-mass-murder-a-crime-on-a-grand-scale Summary: The article discusses alarming findings from German doctors and lawyers regarding the blood of […]

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Overview of the Main Anti-SARS-CoV-2 Vaccines

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Mascellino, M. T., Di Timoteo, F., De Angelis, M., & Oliva, A. (2021). Overview of the main anti-SARS-CoV-2 vaccines: Mechanism of action, efficacy and safety. Infection and Drug Resistance, 14, 3459–3476. https://doi.org/10.2147/IDR.S315727 Summary: The article reviews the principal vaccines developed against SARS-CoV-2 during the Covid-19 pandemic, detailing their mechanisms of action, efficacy, safety, and

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

SARS-CoV-2 mRNA Vaccination and Myocarditis in Adolescents

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Høeg, T. B., Krug, A., Stevenson, J., & Mandrola, J. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12-17: A stratified national database analysis. medRxiv. https://doi.org/10.1101/2021.08.30.21262866 Summary: This study investigates the incidence of myocarditis in adolescents aged 12-17 following mRNA COVID-19 vaccinations. Using data from the Vaccine Adverse Event Reporting System (VAERS), the authors

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

The Risks of mRNA Vaccination in Adolescents: Myocarditis Concerns

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Høeg, T. B., Krug, A., Stevenson, J., & Mandrola, J. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12-17: A stratified national database analysis. medRxiv. https://doi.org/10.1101/2021.08.30.21262866 Summary: This article investigates the incidence of myocarditis following mRNA COVID-19 vaccination in children aged 12-17, as reported through the Vaccine Adverse Event Reporting System (VAERS). It highlights

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

US COVID-19 Vaccines: A Critical Analysis of Health Impact

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Classen, B. (2021). US COVID-19 vaccines proven to cause more harm than good based on pivotal clinical trial data analysed using the proper scientific endpoint, “all cause severe morbidity”. Trends in Internal Medicine, 1(1), 1-6. Summary: The article by J. Bart Classen critiques the three COVID-19 vaccines approved in the US, asserting that they

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

SAHPRAs Monitoring of COVID-19 Vaccine Adverse Events

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: South African Health Products Regulatory Authority. (2021, August 20). SAHPRA statement on adverse events following immunisation (AEFIs) with COVID-19 vaccines. Summary: The South African Health Products Regulatory Authority (SAHPRA) oversees the safety of COVID-19 vaccines in collaboration with the National Department of Health (NDoH). Since the national vaccination roll-out commenced on 17 May 2021,

COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Rising Hospitalisations Among Vaccinated Individuals in Israel

| | COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Johnson, L. D. (2021, August 11). 95% of severe patients in Israeli hospitals are vaccinated, warns doctor. Natural News. https://www.naturalnews.com/2021-08-11-95-severe-patients-israeli-hospitals-are-vaccinated.html Summary: Dr. Kobi Haviv reports a troubling trend in Israel, where 95% of severe COVID-19 patients in hospitals are vaccinated. Despite over 78% vaccination coverage, Israel has experienced a rise in serious cases. The

COVID-19, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Breakthrough Infections Post-Pfizer Vaccination: Insights from an Israeli Study

| | COVID-19, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Brosh-Nissimov, T. et al. (2021). BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2021.06.036 Summary: A study conducted in Israel examined breakthrough infections in fully-vaccinated patients who were hospitalised with COVID-19. Out of 152 patients, 40% were immunocompromised, and the study revealed that despite the

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Should COVID-19 Vaccination in Children be Mandatory?

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Benn, C. S., & Aaby, P. (2021). Should COVID-19 be a vaccine disease or a childhood disease? The BMJ, 374, n1687. https://doi.org/10.1136/bmj.n1687 Summary: The article discusses the implications of COVID-19 vaccination for children, highlighting concerns over the safety and necessity of such measures. It critiques the small sample size of the Pfizer phase 3

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

The Impact of the Johnson & Johnson Vaccine on Thrombus Risk in Hypercoagulable Patients

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Rutenberg, D., & Zhang, Y. (2021). The clot thickens: Does the Johnson & Johnson COVID-19 vaccine increase the risk of thrombus in a hypercoagulable state? Chest, 2195. https://doi.org/10.1016/j.chest.2021.07.1937 Summary: Since January 2020, Elsevier has provided a COVID-19 resource centre offering free access to information on the novel coronavirus. The resource centre allows unrestricted sharing

Scroll to Top